Cardiac rhabdomyoma can be subclinical or have a fatal presentation according to the onset age and involved site, size, and degree of invasion. Although most cardiac rhabdomyomas become smaller with time, emergency intervention is indicated when severe obstruction has occurred. In this report, we describe the spontaneous regression of a large cardiac rhabdomyoma (20.5 × 15.6 mm) presenting as s...

Cardiac complications of non-cardiac surgeries are an actual and unresolved interdisciplinary problem clinical medicine today. The incidence cardiovascular events after surgery is higher than in the general population does not tend to decrease. risk cardiac cancer highest. Evidence-based approaches assessment prevention surgical patients with malignant neoplasms have been developed. In current ...

An important cornerstone in cardiovascular research has been the identification of markers that not only relate to clinical disease but are also indicative of subclinical disease. In recent years, N-terminal pro-B–type natriuretic peptide (NT-proBNP) has emerged as such a marker, associated in particular with heart failure. NT-proBNP is a biologically inactive metabolite secreted together with ...

historically, biomarkers have been used in two major ways to maintain and improve better health status: first, for diagnostic purposes, and second, as specific targets to treat various diseases.   a new era in treatment and even cure for the some diseases using reprograming of somatic cells is about to be born. in this approach, scientists are successfully taking human skin cells (previously co...